Suppr超能文献

口服特比萘芬治疗甲真菌病

Management of onychomycosis with oral terbinafine.

作者信息

Zaias N

机构信息

Mount Sinai Hospital, Miami Beach, FL.

出版信息

J Am Acad Dermatol. 1990 Oct;23(4 Pt 2):810-2. doi: 10.1016/0190-9622(90)70295-s.

Abstract

The safety and efficacy of oral terbinafine in the treatment of finger onychomycosis caused by Trichophyton rubrum were evaluated in an open study including 11 patients. Treatment consisted of 125 mg of terbinafine given twice daily for 6 months or until the infection cleared. At the end of the treatment period, all patients were clinically and mycologically normal, with the drug acting as a fungal barrier to prevent further distal fungal invasion into the nailplate. Mild gastric discomfort in one patient was the only side effect reported during this study. No laboratory abnormalities were detected.

摘要

在一项纳入11例患者的开放性研究中,评估了口服特比萘芬治疗红色毛癣菌引起的手指甲癣的安全性和有效性。治疗方案为每日2次口服125mg特比萘芬,持续6个月或直至感染清除。在治疗期结束时,所有患者在临床和真菌学方面均恢复正常,药物起到了真菌屏障的作用,防止真菌进一步向远端侵袭至甲板。该研究期间报告的唯一副作用是1例患者出现轻度胃部不适。未检测到实验室异常。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验